142 related articles for article (PubMed ID: 32527460)
21. Alpinumisoflavone against cancer pro-angiogenic targets: In silico, In vitro, and In ovo evaluation.
Alos HC; Billones JB; Castillo AL; Vasquez RD
Daru; 2022 Dec; 30(2):273-288. PubMed ID: 35925539
[TBL] [Abstract][Full Text] [Related]
22. 6-Bromoquinazoline Derivatives as Potent Anticancer Agents: Synthesis, Cytotoxic Evaluation, and Computational Studies.
Zare S; Emami L; Behrouz M; Khankahdani RA; Nickpour S; Emami M; Faghih Z; Khabnadideh S
Chem Biodivers; 2023 Jul; 20(7):e202201245. PubMed ID: 37191970
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and
Shehta W; Agili F; Farag B; Youssif S; Almehmadi SJ; Elfeky SM; El-Kalyoubi S
Future Med Chem; 2023 Apr; 15(8):661-677. PubMed ID: 37125606
[No Abstract] [Full Text] [Related]
24. Targeting Colon Cancer Cells with Pyrazino-Imidazolinone Derivatives: Synthesis, Molecular Docking, and in Vitro Evaluation of Anti-Proliferative and Pro-Apoptotic Activities.
Tambat N; Tambe P; Shaikh A; Shiekh KN; Köhler LHF; Schobert R; Biersack B; Ahmed K
Chem Biodivers; 2023 Aug; 20(8):e202300149. PubMed ID: 37306072
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of coumarin replacements of novobiocin as Hsp90 inhibitors.
Kusuma BR; Khandelwal A; Gu W; Brown D; Liu W; Vielhauer G; Holzbeierlein J; Blagg BS
Bioorg Med Chem; 2014 Feb; 22(4):1441-9. PubMed ID: 24461493
[TBL] [Abstract][Full Text] [Related]
26. Green Synthesis of a Novel Phytoalexin Derivative:
Roy LD; Kumar J
Anticancer Agents Med Chem; 2024; 24(1):66-76. PubMed ID: 37936468
[TBL] [Abstract][Full Text] [Related]
27. Design, Synthesis of Novel 1,2,3-Triazole Pendent Quinazolinones and Their Cytotoxicity against MCF-7 Cell Line.
Myakala N; Kandula K; Rayala N; Kuna S; Thumma V; Durga Bhavani Anagani K
Chem Biodivers; 2023 Dec; 20(12):e202300800. PubMed ID: 37708234
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of ring-A modified lupeol derivatives and their anti-proliferative activity: identification of potent lead active against MCF-7 breast cancer cells.
Narendar K; Mandha Chander P; Abhisheik Eedara C; Andugulapati SB; Ramalingam V; SureshBabu K; Vijayachari P
Nat Prod Res; 2024; 38(2):304-310. PubMed ID: 36083601
[TBL] [Abstract][Full Text] [Related]
29. Studies on 1,4-Quinone Derivatives Exhibiting Anti-Leukemic Activity along with Anti-Colorectal and Anti-Breast Cancer Effects.
Ciftci H; Sever B; Kaya N; Bayrak N; Yıldız M; Yıldırım H; Tateishi H; Otsuka M; Fujita M; TuYuN AF
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615273
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of novel pyrimido[4,5-b]quinolines as potential anticancer agents and HER2 inhibitors.
Ibrahim NSM; Kadry HH; Zaher AF; Mohamed KO
Chem Biol Drug Des; 2023 Nov; 102(5):996-1013. PubMed ID: 37527951
[TBL] [Abstract][Full Text] [Related]
31. Design and synthesis of Hsp90 inhibitors: exploring the SAR of Sansalvamide A derivatives.
Sellers RP; Alexander LD; Johnson VA; Lin CC; Savage J; Corral R; Moss J; Slugocki TS; Singh EK; Davis MR; Ravula S; Spicer JE; Oelrich JL; Thornquist A; Pan CM; McAlpine SR
Bioorg Med Chem; 2010 Sep; 18(18):6822-56. PubMed ID: 20708938
[TBL] [Abstract][Full Text] [Related]
32. Quinazolinone derivatives as new potential CDK4/6 inhibitors, apoptosis inducers and radiosensitizers for breast cancer.
El-Gazzar MG; El-Gazzar MG; Ghorab MM
Future Med Chem; 2023 Jul; 15(13):1133-1147. PubMed ID: 37529897
[No Abstract] [Full Text] [Related]
33. Synthesis and antiproliferative activities of quebecol and its analogs.
Pericherla K; Shirazi AN; Rao VK; Tiwari RK; DaSilva N; McCaffrey KT; Beni YA; González-Sarrías A; Seeram NP; Parang K; Kumar A
Bioorg Med Chem Lett; 2013 Oct; 23(19):5329-31. PubMed ID: 23953195
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, cytotoxicity, antioxidant activity and molecular modeling of new NSAIDs-EBS derivatives.
Zhong M; Lu Y; Li S; Li X; Liu Z; He X; Zhang Y
Eur J Med Chem; 2023 Nov; 259():115662. PubMed ID: 37482018
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and anticancer activity evaluation of 7-oxygen-substituted and 8,17-epoxydized 1,2-didehydro-3-ox-14-deoxyandrographolide derivatives.
Han W; Li J; Li Q; Yang Y; Li J; Xue X
Fitoterapia; 2022 Nov; 163():105347. PubMed ID: 36336137
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, computational study and cytotoxic evaluation of some new quinazoline derivatives containing pyrimidine moiety.
Zare S; Emami L; Faghih Z; Zargari F; Faghih Z; Khabnadideh S
Sci Rep; 2023 Sep; 13(1):14461. PubMed ID: 37660139
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and Molecular modeling study of certain EGFRinhibitors with a quinazolinone scaffold as anti-hepatocellular carcinoma and Radio-sensitizers.
Ghorab WM; El-Sebaey SA; Ghorab MM
Bioorg Chem; 2023 Feb; 131():106310. PubMed ID: 36528923
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, evaluation of anti-breast cancer activity in vitro of ICS II derivatives and summary of the structure-activity relationship.
Zhang L; Qin X; Lian C; Liu J
Bioorg Med Chem; 2023 Mar; 81():117188. PubMed ID: 36753987
[TBL] [Abstract][Full Text] [Related]
39. Discovery of potent heat shock protein 90 (Hsp90) inhibitors: structure-based virtual screening, molecular dynamics simulation, and biological evaluation.
Xu Y; Zou Y; Zhou S; Niu MM; Zhang Y; Li J; Xu Z; Yang L
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2220558. PubMed ID: 37357755
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, molecular docking, and in-vitro studies of pyrimidine-2-thione derivatives as antineoplastic agents via potential RAS/PI3K/Akt/JNK inhibition in breast carcinoma cells.
Salem MM; Gerges MN; Noser AA
Sci Rep; 2022 Dec; 12(1):22146. PubMed ID: 36550279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
